Edgewell Personal Care (EPC) 10-Q 10 Feb 25 2025 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Dec. 31, 2024	Jan. 31, 2025
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Dec. 31, 2024
Document Transition Report	false
Entity File Number	001-15401
Entity Registrant Name	EDGEWELL PERSONAL CARE COMPANY
Entity Incorporation, State or Country Code	MO
Entity Tax Identification Number	43-1863181
Entity Address, Address Line One	6 Research Drive
Entity Address, City or Town	Shelton,
Entity Address, State or Province	CT
Entity Address, Postal Zip Code	06484
City Area Code	(203)
Local Phone Number	944-5500
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	EPC
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		48,228,669
Entity Central Index Key	0001096752
Current Fiscal Year End Date	--09-30
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	Q1
Amendment Flag	false

Condensed Consolidated Statemen

Condensed Consolidated Statements of Earnings and Comprehensive Income - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Income Statement [Abstract]
Net sales	$ 478.4	$ 488.9
Cost of products sold	286.8	291.2
Gross profit	191.6	197.7
Selling, general and administrative expense	102.9	103.3
Advertising and sales promotion expense	50.3	48.2
Research and development expense	13.9	13.3
Restructuring charges	4.2	6.8
Operating income	20.3	26.1
Interest expense associated with debt	18.8	19.8
Other expense, net	3.2	0.3
(Loss) earnings before income taxes	(1.7)	6
Income tax provision	0.4	1.2
Net (loss) earnings	(2.1)	4.8
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	(48.3)	27
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax	0.4	(0.1)
Deferred gain (loss) on hedging activity, net of tax	$ 5	$ (3.4)
Basic net (loss) earnings per share	$ (0.04)	$ 0.10
Diluted net (loss) earnings per share	$ (0.04)	$ 0.09
Condensed Consolidated Statements of Comprehensive Income
Net (loss) earnings	$ (2.1)	$ 4.8
Other comprehensive (loss) income, net of tax
Total other comprehensive (loss) income, net of tax	(42.9)	23.5
Total comprehensive (loss) income	$ (45)	$ 28.3
Basic weighted-average shares outstanding (in shares)	48.7	50.1
Weighted Average Number of Shares Outstanding, Diluted	48.7	50.5

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Earnings and Comprehensive Income (Parenthetical) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Income Statement [Abstract]
Pension and postretirement activity, tax	$ 0.4	$ (0.6)
Deferred gain on hedging activity, tax	$ 2.3	$ (1.6)
Diluted net (loss) earnings per share	$ (0.04)	$ 0.09

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2024	Sep. 30, 2024
Current assets
Cash and cash equivalents	$ 175.5	$ 209.1
Trade receivables, less allowance for doubtful accounts	120.5	109.4
Inventories	501.6	477.3
Other current assets	147.6	140.2
Total current assets	945.2	936
Property, plant and equipment, net	342.7	349.1
Goodwill	1,328.7	1,338.6
Other intangible assets, net	934.3	948.5
Other assets	151.5	158.7
Total assets	3,702.4	3,730.9
Current liabilities
Notes payable	27.2	24.5
Accounts payable	203.8	219.3
Other current liabilities	228	319.8
Total current liabilities	459	563.6
Long-term debt	1,440.6	1,275
Deferred income tax liabilities	132.6	133.2
Other liabilities	169.2	175
Liabilities, Total	2,201.4	2,146.8
Shareholders’ equity
Preferred shares	0	0
Common shares	0.7	0.7
Additional paid-in capital	1,561.8	1,586
Retained earnings	1,080.9	1,090.1
Common shares in treasury at cost	(944.7)	(937.9)
Accumulated other comprehensive loss	(197.7)	(154.8)
Total shareholders’ equity	1,501	1,584.1
Total liabilities and shareholders’ equity	$ 3,702.4	$ 3,730.9

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2024	Sep. 30, 2024
Statement of Financial Position [Abstract]
Preferred shares, par value (in usd per share)	$ 0.01	$ 0.01
Preferred shares, authorized (in shares)	10,000,000	10,000,000
Preferred shares, issued (in shares)	0	0
Preferred shares, outstanding (in shares)	0	0
Common shares, par value (in usd per share)	$ 0.01	$ 0.01
Common shares, authorized (in shares)	300,000,000	300,000,000
Common shares, issued (in shares)	65,251,989	65,251,989
Common shares, outstanding (in shares)	48,415,888	48,920,813
Treasury Stock, Common, Shares	16,836,101	16,331,176
Accounts Receivable, Allowance for Credit Loss	$ 4.4	$ 4.6

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Cash Flow from Operating Activities
Net (loss) earnings	$ (2.1)	$ 4.8
Depreciation and amortization	21.7	22.5
Share-based compensation expense	6.1	7
Loss on sale of assets	1.4	0.1
Deferred compensation payments	(0.2)	(0.4)
Deferred income taxes	0.2	(0.2)
Proceeds (payments) for other operating activities	2.3	(0.6)
Other, net	(145)	(106.1)
Net cash used for operating activities	(115.6)	(72.9)
Cash Flow from Investing Activities
Capital expenditures	(16.8)	(6.5)
Collection of deferred purchase price on accounts receivable sold	1.1	0
Payments for (Proceeds from) Other Investing Activities	0	(0.5)
Other, net	0	0.5
Net cash used for investing activities	(15.7)	(6)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	369	216
Cash payments on debt with original maturities greater than 90 days	(204)	(125)
Proceeds from debt with original maturities of 90 days or less	3.7	4.1
Repurchase of shares	(30.3)	(15)
Dividends to common shareholders	(7.9)	(7.6)
Net financing (outflow) inflow from the Accounts Receivable Facility	(13.3)	4.8
Employee shares withheld for taxes	(7.3)	(7)
Proceeds (payments) for other financing activities	0	(0.5)
Net cash provided by financing activities	109.9	69.8
Effect of exchange rate changes on cash	(12.2)	6.9
Net decrease in cash and cash equivalents	(33.6)	(2.2)
Cash and cash equivalents, beginning of period	209.1	216.4
Cash and cash equivalents, end of period	$ 175.5	$ 214.2

Condensed Consolidated Statem_4

Condensed Consolidated Statement of Changes in Shareholders' Equity Statement - USD ($) $ in Millions	Total	Other expense (income), net Reclassification out of Accumulated Other Comprehensive Income	Common shares	Treasury Stock, Common	Additional paid-in capital	Retained earnings	Accumulated other comprehensive loss
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury Stock, Common, Shares				(15,000,000)
Common shares, issued (in shares)			65,200,000
Treasury Stock, Common, Shares				(15,000,000)
Beginning shareholders' equity at Sep. 30, 2023	$ 1,540.5		$ 0.7	$ (906.1)	$ 1,593.8	$ 1,022.1	$ (170)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) earnings	4.8					4.8
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	27						27
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax	(0.1)						(0.1)
Deferred gain (loss) on hedging activity, net of tax	(3.4)						(3.4)
Dividends declared to common shareholders	(7.6)					(7.6)
Treasury shares repurchased (in usd)	(15.5)			$ (15.5)
Treasury shares repurchased (in shares)				(400,000)
Activity under share plans (shares)				200,000
Activity under share plans (in usd)	0.1			$ 25
APIC activity under share plans					(24.9)
Ending shareholders' equity at Dec. 31, 2023	$ 1,545.8		$ 0.7	$ (896.6)	1,568.9	1,019.3	(146.5)
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
OCI Cash flow hedges reclass to earnings, before tax		$ 1.6
Treasury Stock, Common, Shares				(15,200,000)
Common shares, issued (in shares)			65,200,000
Treasury Stock, Common, Shares				(15,200,000)
Treasury Stock, Common, Shares	16,331,176			(16,300,000)
Common shares, issued (in shares)	65,251,989		65,200,000
Treasury Stock, Common, Shares	16,331,176			(16,300,000)
Beginning shareholders' equity at Sep. 30, 2024	$ 1,584.1		$ 0.7	$ (937.9)	1,586	1,090.1	(154.8)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) earnings	(2.1)					2.1
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	(48.3)						(48.3)
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax	0.4						0.4
Deferred gain (loss) on hedging activity, net of tax	5						5
Dividends declared to common shareholders	(7.1)					(7.1)
Treasury shares repurchased (in usd)	$ (30.1)			$ (30.1)
Treasury shares repurchased (in shares)	(800,000)			(800,000)
Activity under share plans (shares)				300,000
Activity under share plans (in usd)	$ (0.9)			$ 23.3
APIC activity under share plans					(24.2)
Ending shareholders' equity at Dec. 31, 2024	$ 1,501		$ 0.7	$ (944.7)	$ 1,561.8	$ 1,080.9	$ (197.7)
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
OCI Cash flow hedges reclass to earnings, before tax		$ 0.5
Treasury Stock, Common, Shares	16,836,101			(16,800,000)
Common shares, issued (in shares)	65,251,989		65,200,000
Treasury Stock, Common, Shares	16,836,101			(16,800,000)

Background and Basis of Present

Background and Basis of Presentation	3 Months Ended
	Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Background and Basis of Presentation	Background and Basis of Presentation Background Edgewell Personal Care Company and its subsidiaries (collectively, “Edgewell” or the “Company”) is one of the world’s largest manufacturers and marketers of personal care products in the wet shave, sun and skin care, and feminine care categories. With operations in approximately 20 countries, the Company’s products are widely available in more than 50 countries. The Company conducts its business in the following three segments: • Wet Shave consists of products sold under the Schick®, Wilkinson Sword TM , Edge, Skintimate®, Billie®, Shave Guard and our custom brands group (formerly sold under our Shave Guard and Personna® brands), as well as non-branded products. The Company’s wet shave products include razor handles and refillable blades, disposable shave products, and shaving gels and creams. • Sun and Skin Care consists of Banana Boat® and Hawaiian Tropic® sun care products, Jack Black®, Bulldog® and Cremo® men’s and women’s grooming products, Billie women’s grooming products and Wet Ones® products. • Feminine Care includes tampons, pads and liners sold under the Playtex Gentle Glide® and Sport®, Stayfree®, Carefree®, and o.b.® brands. Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements include the accounts of the Company and its controlled subsidiaries and have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”) under the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). The preparation of the unaudited Condensed Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. Actual results may differ materially from those estimates. All intercompany balances and transactions have been eliminated in consolidation and, in the opinion of management, all normal recurring adjustments considered necessary for a fair statement have been included in the interim results reported. The fiscal year-end balance sheet data was derived from audited consolidated financial statements, but do not include all of the annual disclosures required by GAAP; accordingly, these unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Company’s audited annual consolidated financial statements included in its Annual Report on Form 10-K filed with the SEC on November 14, 2024, as amended on November 21, 2024. Recently Issued Accounting Pronouncements In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2024-03 Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40). Additionally, in January 2025, the FASB issued ASU 2025-01 to clarify the effective date of ASU 2024-03. ASU 2024-03 provides guidance to expand disclosures related to the disaggregation of income statement expenses. The standard requires, in the notes to the financial statements, disclosure of specified information about certain costs and expenses which includes purchases of inventory, employee compensation, depreciation, and intangible asset amortization included in each relevant expense caption. This guidance is effective for fiscal years beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027, on a retrospective or prospective basis, with early adoption permitted. We are currently evaluating this ASU to determine its impact on our consolidated financial statements and disclosures. In December 2023, the FASB issued ASU No. 2023-09 Income Taxes (Topic 740): Improvements to Income Tax Disclosures to update income tax disclosure requirements primarily by requiring specific categories and greater disaggregation within the rate reconciliation and disaggregation of income taxes paid by jurisdiction. The amendments in the ASU also remove disclosures related to certain unrecognized tax benefits and deferred taxes. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. The amendments may be applied prospectively or retrospectively and early adoption is permitted. We are currently assessing the impact of the requirements on our consolidated financial statements and disclosures. In November 2023, the FASB issued ASU No. 2023-07 Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures to expand reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in the ASU require that a public entity disclose, on an annual and interim basis, significant segment expenses that are regularly provided to an entity's chief operating decision maker (“CODM”), a description of other segment items by reportable segment, and any additional measures of a segment's profit or loss used by the CODM when deciding how to allocate resources. Annual disclosures are required for fiscal years beginning after December 15, 2023. Interim disclosures are required for periods within fiscal years beginning after December 15, 2024. Retrospective application is required for all prior periods presented and early adoption is permitted. We are currently assessing the impact of the requirements on our consolidated financial statements and disclosures. No other new accounting pronouncement issued or effective during the fiscal year had, or is expected to have, a material impact on our Condensed Consolidated Financial Statements.
Supplier Finance Program	Recently Adopted Accounting Pronouncements In September 2022, the FASB issued Accounting Standards Update 2022-04, " Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations " which requires that a buyer in a supplier finance program disclose additional information about the program for financial statement users including a rollforward of those obligations. The Company adopted the standard as of October 1, 2023, except for amendments relating to the rollforward requirement, which is effective for fiscal years beginning after December 15, 2023.

Restructuring Charges

Restructuring Charges	3 Months Ended
	Dec. 31, 2024
Restructuring Charges [Abstract]
Restructuring Charges	Restructuring Charges Operating Model Redesign In fiscal 2025, the Company continues to take actions to strengthen its operating model, simplify the organization’s ways of working and improve manufacturing and supply chain efficiency and productivity. As a result of these actions, the Company expects to incur restructuring and repositioning related charges of approximately $11 in fiscal 2025. The Company has incurred restructuring and repositioning related charges as follows: Three Months Ended December 31, 2024 2023 Severance and related costs $ 0.5 $ 3.9 Asset write-off and accelerated depreciation 1.0 0.1 Consulting, project implementation and management, and other exit costs 0.9 2.8 Total restructuring and repositioning charges $ 2.4 $ 6.8 Consolidation of Mexico Facilities In fiscal 2024, the Company announced certain operational and organizational steps designed to streamline the Company’s operations and supply chain by consolidating its current Mexico operations in Obregon and Mexico City into a single facility in Aguascalientes, Mexico. As a result of these actions, the Company is anticipating incurring restructuring and repositioning charges of $18 in fiscal 2025 and is expected to be completed by the second quarter of fiscal 2026. Three Months Ended December 31, 2024 2023 Severance and related benefit costs (1) $ (0.3) $ — Consulting, project implementation and management, and other exit costs 2.1 — Total restructuring and repositioning charges (2) $ 1.8 $ — (1) Due to natural workforce attrition, the Company has recorded an adjustment to the severance accrual that was recorded as of September 30, 2024. (2) The Company does not include restructuring costs in the results of its reportable segments; however, these charges are related to the Wet Shave segment.

Income Taxes

Income Taxes	3 Months Ended
	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The source of income taxes are below: Three Months Ended December 31, 2024 2023 (Loss) earnings before income taxes $ (1.7) $ 6.0 Income tax provision 0.4 1.2 Effective tax rate (21.7) % 20.1 % For the three months ended December 31, 2024, the difference between the federal statutory rate and the effective rate was primarily due to an unfavorable mix of earnings in higher tax rate jurisdictions. For the three months ended December 31, 2023, the difference between the federal statutory rate and the effective rate was primarily due to a favorable mix of earnings in lower tax rate jurisdictions.

Earnings per Share

Earnings per Share	3 Months Ended
	Dec. 31, 2024
Earnings Per Share [Abstract]
Earnings per Share	(Loss) Earnings per Share Basic (loss) earnings per share is based on the weighted-average number of common shares outstanding during the period. Diluted net (loss) earnings per share is based on the number of shares used for the basic (loss) earnings per share calculation, adjusted for the dilutive effect of share options, restricted share equivalent (“RSE”) and performance restricted share equivalent (“PRSE”) awards. The following is the reconciliation between the number of weighted-average shares used in the basic and diluted net (loss) earnings per share calculation: Three Months Ended 2024 2023 Basic weighted-average shares outstanding 48.7 50.1 Effect of dilutive securities: Options, RSE and PRSE awards — 0.4 Total dilutive securities — 0.4 Diluted weighted-average shares outstanding 48.7 50.5 For the three months ended December 31, 2024, the calculation of diluted weighted-average shares outstanding excludes 0.5 of options, RSE and PRSE awards that would have otherwise been dilutive, because the Company reported a net loss. The following weighted-average common shares were excluded from the calculation of diluted net (loss) earnings per share because the effect of including these awards was antidilutive. Three Months Ended 2024 2023 Options, RSE and PRSE awards 1.4 1.9

Goodwill and Intangible Assets

Goodwill and Intangible Assets	3 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets The following table sets forth goodwill by segment: Wet Sun and Skin Feminine Total Gross balance as of September 30, 2024 $ 1,146.0 $ 357.4 $ 206.2 $ 1,709.6 Accumulated goodwill impairment (369.0) (2.0) — (371.0) Net balance as of September 30, 2024 $ 777.0 $ 355.4 $ 206.2 $ 1,338.6 Changes in the three months ended December 31, 2024 Cumulative translation adjustment $ (6.3) $ (1.1) $ (2.5) $ (9.9) Gross balance as of December 31, 2024 $ 1,139.7 $ 356.3 $ 203.7 $ 1,699.7 Accumulated goodwill impairment (369.0) (2.0) — (371.0) Net balance as of December 31, 2024 $ 770.7 $ 354.3 $ 203.7 $ 1,328.7 The following table sets forth intangible assets by class: December 31, 2024 September 30, 2024 Carrying Accumulated Net Carrying Accumulated Net Indefinite lived Trade names and brands $ 592.2 $ — $ 592.2 $ 597.7 $ — $ 597.7 Amortizable Trade names and brands $ 339.6 $ 107.7 $ 231.9 $ 339.8 $ 104.0 $ 235.8 Technology and patents 79.2 76.9 2.3 79.7 77.3 2.4 Customer related and other 269.7 161.8 107.9 272.5 159.9 112.6 Amortizable intangible assets 688.5 346.4 342.1 692.0 341.2 350.8 Total intangible assets $ 1,280.7 $ 346.4 $ 934.3 $ 1,289.7 $ 341.2 $ 948.5 Amortization expenses were $7.8 and $7.8 for the three months ended December 31, 2024 and 2023, respectively. Estimated amortization expense for amortizable intangible assets is as follows: Estimated amortization expense Remainder of fiscal year 2025 $ 23.2 2026 30.6 2027 30.4 2028 30.4 2029 30.3 2030 30.3 Thereafter 166.9 Goodwill and intangible assets deemed to have an indefinite life are not amortized but are instead reviewed annually for impairment or when indicators of a potential impairment are present. The Company’s annual impairment testing date is July 1. An interim impairment analysis may indicate that carrying amounts of goodwill and other intangible assets require adjustment or that remaining useful lives should be revised. The Company determined there were no triggering events requiring an interim impairment analysis during the three months ended December 31, 2024.

Supplemental Balance Sheet Info

Supplemental Balance Sheet Information	3 Months Ended
	Dec. 31, 2024
Supplemental Balance Sheet Information [Abstract]
Supplemental Balance Sheet Information	Supplemental Balance Sheet Information December 31, September 30, Other Current Assets Prepaid expenses $ 79.8 $ 76.4 Value added tax receivables 34.1 40.0 Income taxes receivable 18.5 14.7 Other 15.2 9.1 Total other current assets $ 147.6 $ 140.2 Other Current Liabilities Accrued advertising and sales promotion $ 23.3 $ 26.3 Accrued trade allowances 23.8 28.7 Accrued salaries, vacations and incentive compensation 32.1 78.6 Income taxes payable 9.2 13.6 Returns reserve 24.7 50.3 Accrued interest 9.5 24.7 Other 105.4 97.6 Total other current liabilities $ 228.0 $ 319.8 Other Liabilities Pensions and other retirement benefits $ 43.6 $ 45.6 Other 125.6 129.4 Total other liabilities $ 169.2 $ 175.0

Accounts Receivable Facility

Accounts Receivable Facility	3 Months Ended
	Dec. 31, 2024
Transfers and Servicing [Abstract]
Accounts receivable facility	Accounts Receivable Facilities The Company participates in accounts receivable facility programs both in the United States and Japan. These receivable agreements are between the Company and MUFG Bank, LTD (“MUFG”), and the subsidiaries of both parties. Transfers under the accounts receivable repurchase agreements are accounted for as sales of accounts receivables, resulting in the receivables being derecognized from the Condensed Consolidated Balance Sheets. MUFG, as the purchaser assumes the credit risk at the time of sale and has the right at any time to assign, transfer, or participate any of its rights under the purchased receivables to another bank or financial institution. The purchase and sale of receivables under accounts receivable repurchase agreements is intended to be an absolute and irrevocable transfer without recourse by the purchaser to the Company for the creditworthiness of any obligor. The Company has considered its performance obligation to collect and service the receivables sold in the United States and Japan and has determined that the costs associated with such services are not material. The Company has deemed the compensation received acceptable servicing compensation and as such, the Company does not recognize a servicing asset or liability. Accounts receivables sold were $223.9 and $216.1 for the three months ended December 31, 2024 and 2023, respectively. The trade receivables sold that remained outstanding as of December 31, 2024 and September 30, 2024 were $81.5 and $88.6, respectively. The net proceeds received were included in both Cash provided by operating activities and Cash used by investing activities on the Condensed Consolidated Statements of Cash Flows. The subsequent cash collections and remittances of cash to the MUFG for receivables serviced by the Company are considered financing cash flow activity and are presented net for the period. The difference between the carrying amount of the trade receivables sold and the sum of the cash received is recorded as a loss on sale of receivables in Other expense, net in the Condensed Consolidated Statements of Earnings and Comprehensive (Loss) Income. The loss on sale of trade receivables was $1.1 and $1.2 for the three months ended December 31, 2024 and 2023

Debt

Debt	3 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
Debt	Debt The detail of long-term debt was as follows: December 31, September 30, Senior notes, fixed interest rate of 5.5%, due 2028 $ 750.0 $ 750.0 Senior notes, fixed interest rate of 4.1%, due 2029 500.0 500.0 U.S. Revolving Credit Facility 199.0 34.0 Total 1,449.0 1,284.0 Less unamortized debt issuance costs and discount (1) 8.4 9.0 Total long-term debt $ 1,440.6 $ 1,275.0 (1) As of December 31, 2024, debt issuance costs were $5.0 and $3.4 related to the Senior Notes due 2028 and the Senior Notes due 2029, respectively. As of September 30, 2024, debt issuance costs were $5.4 and $3.6 related to the Senior Notes due 2028 and the Senior Notes due 2029, respectively. As of December 31, 2024 and September 30, 2024 , the Company also had outstanding short-term notes payable with financial institutions with original maturities of less than 90 days of $27.2 a

Retirement Plans

Retirement Plans	3 Months Ended
	Dec. 31, 2024
Retirement Benefits [Abstract]
Retirement Plans	Retirement Plans The Company has several defined benefit pension plans covering employees in the U.S. and certain employees in other countries. The plans provide retirement benefits based on years of service and compensation. The Company also sponsors or participates in several other non-U.S. pension and postretirement arrangements, including various retirement and termination benefit plans, some of which are required by local law or coordinated with government-sponsored plans, which are not significant in the aggregate and, therefore, are not included in the information presented below. The Company’s net periodic pension and postretirement costs for its material plans were as follows: Three Months Ended 2024 2023 Service cost $ 0.6 $ 0.5 Interest cost 4.5 5.3 Expected return on plan assets (5.4) (4.9) Recognized net actuarial loss 0.6 0.4 Net periodic cost $ 0.3 $ 1.3 The service cost component of the net periodic cost associated with the Company’s retirement plans is recorded to Cost of products sold and SG&A on the Condensed Consolidated Statement of Earnings and Comprehensive (Loss) Income. The remaining net periodic cost is recorded to Other expense, net on the Condensed Consolidated Statement of Earnings and Comprehensive (Loss) Income.

Equity

Equity	3 Months Ended
	Dec. 31, 2024
Equity [Abstract]
Shareholders' Equity	Shareholders’ Equity Share Repurchases In January 2018, the Company’s Board of Directors (the “Board”) authorized the repurchase of up to 10.0 shares of the Company’s common stock, replacing the previous share repurchase authorization from May 2015. The Company repurchased 0.8 shares of its common stock for $30.3 during the three months ended December 31, 2024. As of December 31, 2024, there are 2.2 shares of common stock available for repurchase in the future under the Board’s authorization. Any future share repurchases may be made in the open market, privately negotiated transactions, or otherwise permitted, and in such amounts and at such times as the Company deems appropriate based upon prevailing market conditions, business needs, and other factors. Dividends Dividend activity in the three months ended December 31, 2024 are as follows: Date Declared Record Date Payable Date Amount Per Share August 6, 2024 September 4, 2024 October 3, 2024 $ 0.15 October 31, 2024 December 3, 2024 January 8, 2025 $ 0.15 On February 6, 2025, the Board declared a quarterly cash dividend of $0.15 per common share for the first fiscal quarter of 2025. The dividend will be payable on April 9, 2025 to shareholders of record as the close of business on March 5, 2025. Dividends declared during the three months ended December 31, 2024 totaled $7.1. Payments made for dividends during the three months ended December 31, 2024 totaled $7.9.

Financial Instruments and Risk

Financial Instruments and Risk Management	3 Months Ended
	Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Financial Instruments and Risk Management	Financial Instruments and Risk Management In the ordinary course of business, the Company may enter into contractual arrangements (also referred to as derivatives) to reduce its exposure to foreign currency. The Company has master netting agreements with certain of its counterparties as set forth in detail below that allow for the settlement of contracts in an asset position with contracts in a liability position in the event of default. The Company manages counterparty risk through the utilization of investment grade commercial banks, diversification of counterparties, and its counterparty netting arrangements. The section below outlines the types of derivatives in place as of December 31, 2024 and September 30, 2024, as well as the Company’s objectives and strategies for holding derivative instruments. Foreign Currency Risk A significant share of the Company’s sales is tied to currencies other than the U.S. dollar, the Company’s reporting currency. As such, a weakening of currencies relative to the U.S. dollar can have an unfavorable impact on reported earnings. Conversely, strengthening of currencies relative to the U.S. dollar can improve reported results. The primary currencies to which the Company is exposed include the euro, the Japanese yen, the British pound, the Canadian dollar, and the Australian dollar. Additionally, the Company’s foreign subsidiaries enter into internal and external transactions that create non-functional currency balance sheet positions at the foreign subsidiary level. These exposures are generally the result of intercompany purchases, intercompany loans and, to a lesser extent, external purchases, and are revalued in the foreign subsidiary’s local currency at the end of each month. Changes in the value of the non-functional currency balance sheet positions in relation to the foreign subsidiary’s local currency results in an exchange gain or loss recorded in Other expense, net in the Condensed Consolidated Statements of Earnings and Comprehensive (Loss) Income. The primary currency to which the Company’s foreign subsidiaries are exposed is the U.S. dollar. Interest Rate Risk The Company has interest rate risk with respect to interest expense on variable rate debt. At December 31, 2024, the Company had $199.0 of variable rate debt outstanding, which consisted primarily of outstanding borrowings under the Revolving Credit Facility in the U.S. Cash Flow Hedges As of December 31, 2024, the Company maintains a cash flow hedging program related to foreign currency risk. These derivative instruments have a high correlation to the underlying exposure being hedged and have been deemed highly effective by the Company for accounting purposes in offsetting the associated risk. The Company has forward currency contracts to hedge cash flow uncertainty associated with currency fluctuations. These transactions are accounted for as cash flow hedges. The Company had unrealized pre-tax gains of $4.8 and pre-tax losses of $2.4 as of December 31, 2024 and September 30, 2024, respectively, on these forward currency contracts, which are accounted for as cash flow hedges and included in AOCI in the Condensed Consolidated Balance Sheets. Assuming foreign exchange rates versus the U.S. dollar remain at December 31, 2024 levels over the next 12 months, the majority of the pre-tax gain included in AOCI in the Condensed Consolidated Balance Sheets as of December 31, 2024 is expected to be included in Other expense, net in the Condensed Consolidated Statements of Earnings and Comprehensive (Loss) Income. Contract maturities for these hedges extend into fiscal 2026. As of December 31, 2024, there were 64 open foreign currency contracts with a total notional value of $99.7. Derivatives not Designated as Hedges The Company has foreign currency derivative contracts, which are not designated as cash flow hedges for accounting purposes, to hedge balance sheet exposures. Any gains or losses on these contracts are expected to be offset by exchange gains or losses on the underlying exposures and, thus, are not expected to be subject to significant market risk. The change in the estimated fair value of the foreign currency contracts for the three months ended December 31, 2024, resulted in a gain of $0.9 compared to a loss of $1.1 for the three months ended December 31, 2023, and was recorded in Other expense, net in the Condensed Consolidated Statements of Earnings and Comprehensive (Loss) Income. As of December 31, 2024, there was The following table provides estimated fair values of derivative instruments: Fair Value of Assets (Liabilities) as of (1) December 31, September 30, Derivatives designated as cash flow hedging relationships: Foreign currency contracts $ 4.8 $ (2.4) Derivatives not designated as cash flow hedging relationships: Foreign currency contracts $ — $ 0.1 (1) Derivative assets are presented in Other current assets or Other assets. Derivative liabilities are presented in Other current liabilities or Other liabilities. The following table provides the pre-tax amounts of gains and losses on derivative instruments: Three Months Ended 2024 2023 Derivatives designated as cash flow hedging relationships: Foreign currency contracts Gain recognized in OCI (1) $ 7.7 $ 1.1 Gain reclassified from AOCI into income (1) (2) 0.5 1.6 Derivatives not designated as cash flow hedging relationships: Foreign currency contracts Gain recognized in income (2) $ 0.9 $ 1.1 (1) Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and have been deemed highly effective by the Company in offsetting associated risk. (2) Gain was recorded in Other expense, net in the Condensed Consolidated Statements of Earnings and Comprehensive (Loss) Income. The following table provides financial assets and liabilities for balance sheet offsetting: As of December 31, 2024 As of September 30, 2024 Assets (1) Liabilities (2) Assets (1) Liabilities (2) Foreign currency contracts Gross amounts of recognized assets (liabilities) $ 4.8 $ — $ 0.1 $ (2.7) Gross amounts offset in the balance sheet — — — 0.3 Net amounts of assets (liabilities) presented in the balance sheet $ 4.8 $ — $ 0.1 $ (2.4) (1) All derivative assets are presented in Other current assets or Other assets on the Condensed Consolidated Balance Sheets. (2) All derivative liabilities are presented in Other current liabilities or Other liabilities on the Condensed Consolidated Balance Sheets. Fair Value Hierarchy Accounting guidance on fair value measurements for certain financial assets and liabilities requires that assets and liabilities carried at fair value be classified in one of the following three categories: Level 1: Quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions or external inputs from inactive markets. The following table sets forth the Company’s financial assets and liabilities, which are carried at fair value and measured on a recurring basis during the period, all of which are classified as Level 2 within the fair value hierarchy: December 31, September 30, Assets (Liabilities) at estimated fair value: Deferred compensation liability $ (21.5) $ (21.1) Derivatives - foreign currency contracts asset 4.8 (2.3) Net assets (liabilities) at estimated fair value $ (16.7) $ (23.4) The estimated fair value of the deferred compensation liability is determined based upon the quoted market prices of the investment options that are offered under the plan. As of December 31, 2024 and September 30, 2024, the estimated fair value of foreign currency contracts is the amount that the Company would receive or pay to terminate the contracts, considering first the quoted market prices of comparable agreements or, in the absence of quoted market prices, factors such as interest rates, currency exchange rates, and remaining maturities. As of December 31, 2024 and September 30, 2024, the Company had no Level 1 financial assets or liabilities, other than pension plan assets, and no Level 3 financial assets or liabilities. As of December 31, 2024 and September 30, 2024, the fair market value of fixed rate long-term debt was $1,162.4 and $1,180.0, respectively, compared to its carrying value of $1,250.0 in each period. The estimated fair value of the long-term debt was estimated using yields obtained from independent pricing sources for similar types of borrowing arrangements which has been determined based on Level 2 inputs.

Segment Data

Segment Data	3 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
Segment Data	Segment Data For an overview of the Company’s segments, refer to Note 1 of the Notes to Condensed Consolidated Financial Statements. Segment performance is evaluated based on segment profit, excluding certain U.S. GAAP items that management does not believe are indicative of ongoing operating performance due to their unusual or non-recurring nature and which may have a disproportionate positive or negative impact on the Company’s financial results in any particular period. Financial items, such as interest income and expense, are managed on a global basis at the corporate level and therefore are excluded from segment profit. The exclusion of such charges from segment results reflects management’s view on how management monitors and evaluates segment operating performance, generates future operating plans and makes strategic decisions regarding the allocation of capital. The Company’s operating model includes some shared business functions across the segments, including product warehousing and distribution, transaction processing functions and, in most cases, combined sales force and management teams. The Company applies a fully allocated cost basis in which shared business functions are allocated between the segments. Segment net sales and profitability are presented below: Three Months Ended 2024 2023 Net Sales Wet Shave $ 294.5 $ 301.7 Sun and Skin Care 120.6 115.4 Feminine Care 63.3 71.8 Total net sales $ 478.4 $ 488.9 Segment Profit Wet Shave $ 46.6 $ 53.7 Sun and Skin Care (3.4) (1.3) Feminine Care 3.2 7.3 Total segment profit 46.4 59.7 General corporate and other expenses (11.6) (16.2) Amortization of intangibles (7.8) (7.8) Interest and other expense, net (21.1) (20.1) Restructuring and repositioning expenses (1) (4.2) (6.8) Acquisition and integration costs (2) (0.5) (0.7) Sun Care reformulation costs (3) (1.0) (0.5) Wet Ones manufacturing plant fire (4) — (1.5) Gain on investment (5) 0.9 — Other project and related costs (6) (2.8) (0.1) Total (loss) earnings before income taxes $ (1.7) $ 6.0 (1) The Company recorded $4.2 and $6.8 for the three months ended December 31, 2024 and 2023, respectively, related to actions to strengthen its operating model and improve manufacturing and supply chain efficiency and productivity. There were no amounts included in pre-tax SG&A or pre-tax Cost of products sold for both the three months ended December 31, 2024 and 2023. See Note 2 of the Notes to Condensed Consolidated Financial Statements. (2) Includes pre-tax SG&A of $0.5 and $0.7 for the three months ended December 31, 2024 and 2023, respectively, for the acquisition of Billie, Inc. on November 29, 2021. (3) Includes pre-tax research and development costs of $1.0 and $0.5 for the ended December 31, 2024 and 2023, respectively, related to the reformulation, recall and destruction of certain Sun Care products. (4) On December 1, 2023, a fire occurred at our Wet Ones manufacturing plant in Sidney, Ohio. There were no injuries reported and damage was limited to a single manufacturing process. As a consequence of the fire damage, there was a partial shutdown of the operations that manufacture Wet Ones raw materials. During the three months ended December 31, 2023, the Company incurred $1.5 in costs related to incremental material charges, labor and absorption as a result of the fire. (5) Includes pre-tax gain of $0.9 for the three months ended December 31, 2024 on the fair value measurement of an equity method investment. (6) Includes pre-tax SG&A of $2.8 and $0.1 for the three months ended December 31, 2024 and 2023, respectively, related to certain corporate project and other related costs. The following table presents the Company’s net sales by geographic area: Three Months Ended 2024 2023 Net Sales to Customers United States $ 244.6 $ 254.2 International 233.8 234.7 Total net sales $ 478.4 $ 488.9 Supplemental product information is presented below for net sales: Three Months Ended 2024 2023 Razors and blades $ 267.4 $ 270.5 Tampons, pads, and liners 63.3 71.8 Sun care products 47.4 51.0 Grooming products 53.0 46.8 Wipes and other skin care 20.2 17.6 Shaving gels and creams 27.1 31.2 Total net sales $ 478.4 $ 488.9

Commitment and Contingencies

Commitment and Contingencies	3 Months Ended
	Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure	Commitments and Contingencies Legal Proceedings The Company and its subsidiaries are subject to a number of legal proceedings in various jurisdictions arising out of its operations during the ordinary course of business. Many of these legal matters are in preliminary stages and involve complex issues of law and fact and may proceed for protracted periods of time. The amount of liability, if any, from these proceedings cannot be determined with certainty. The Company reviews its legal proceedings and claims, regulatory reviews and inspections and other legal proceedings on an ongoing basis and follows appropriate accounting guidance when making accrual and disclosure decisions. The Company establishes accruals for those contingencies when the incurrence of a loss is probable and can be reasonably estimated and discloses the amount accrued and the amount of a reasonably possible loss in excess of the amount accrued if such disclosure is necessary for its financial statements to not be misleading. The Company does not record liabilities when the likelihood that the liability has been incurred is probable, but the amount cannot be reasonably estimated. Based upon present information, the Company believes that its liability, if any, arising from such pending legal proceedings, asserted legal claims, and known potential legal claims which are likely to be asserted, is not reasonably likely to be material to its financial position, results of operations or cash flows, when taking into account established accruals for estimated liabilities.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Pay vs Performance Disclosure
Net (loss) earnings	$ (2.1)	$ 4.8

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Dec. 31, 2024
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false

Organization, Consolidation and

Organization, Consolidation and Presentation of Financial Statements (Policies)	3 Months Ended
	Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business Description and Basis of Presentation	Edgewell Personal Care Company and its subsidiaries (collectively, “Edgewell” or the “Company”) is one of the world’s largest manufacturers and marketers of personal care products in the wet shave, sun and skin care, and feminine care categories. With operations in approximately 20 countries, the Company’s products are widely available in more than 50 countries. The Company conducts its business in the following three segments: • Wet Shave consists of products sold under the Schick®, Wilkinson Sword TM , Edge, Skintimate®, Billie®, Shave Guard and our custom brands group (formerly sold under our Shave Guard and Personna® brands), as well as non-branded products. The Company’s wet shave products include razor handles and refillable blades, disposable shave products, and shaving gels and creams. • Sun and Skin Care consists of Banana Boat® and Hawaiian Tropic® sun care products, Jack Black®, Bulldog® and Cremo® men’s and women’s grooming products, Billie women’s grooming products and Wet Ones® products. • Feminine Care includes tampons, pads and liners sold under the Playtex Gentle Glide® and Sport®, Stayfree®, Carefree®, and o.b.® brands.
Basis of Accounting, Policy	Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements include the accounts of the Company and its controlled subsidiaries and have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”) under the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). The preparation of the unaudited Condensed Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. Actual results may differ materially from those estimates. All intercompany balances and transactions have been eliminated in consolidation and, in the opinion of management, all normal recurring adjustments considered necessary for a fair statement have been included in the interim results reported. The fiscal year-end balance sheet data was derived from audited consolidated financial statements, but do not include all of the annual disclosures required by GAAP; accordingly, these unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Company’s audited annual consolidated financial statements included in its Annual Report on Form 10-K filed with the SEC on November 14, 2024, as amended on November 21, 2024. Recently Issued Accounting Pronouncements In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2024-03 Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40). Additionally, in January 2025, the FASB issued ASU 2025-01 to clarify the effective date of ASU 2024-03. ASU 2024-03 provides guidance to expand disclosures related to the disaggregation of income statement expenses. The standard requires, in the notes to the financial statements, disclosure of specified information about certain costs and expenses which includes purchases of inventory, employee compensation, depreciation, and intangible asset amortization included in each relevant expense caption. This guidance is effective for fiscal years beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027, on a retrospective or prospective basis, with early adoption permitted. We are currently evaluating this ASU to determine its impact on our consolidated financial statements and disclosures. In December 2023, the FASB issued ASU No. 2023-09 Income Taxes (Topic 740): Improvements to Income Tax Disclosures to update income tax disclosure requirements primarily by requiring specific categories and greater disaggregation within the rate reconciliation and disaggregation of income taxes paid by jurisdiction. The amendments in the ASU also remove disclosures related to certain unrecognized tax benefits and deferred taxes. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. The amendments may be applied prospectively or retrospectively and early adoption is permitted. We are currently assessing the impact of the requirements on our consolidated financial statements and disclosures. In November 2023, the FASB issued ASU No. 2023-07 Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures to expand reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in the ASU require that a public entity disclose, on an annual and interim basis, significant segment expenses that are regularly provided to an entity's chief operating decision maker (“CODM”), a description of other segment items by reportable segment, and any additional measures of a segment's profit or loss used by the CODM when deciding how to allocate resources. Annual disclosures are required for fiscal years beginning after December 15, 2023. Interim disclosures are required for periods within fiscal years beginning after December 15, 2024. Retrospective application is required for all prior periods presented and early adoption is permitted. We are currently assessing the impact of the requirements on our consolidated financial statements and disclosures. No other new accounting pronouncement issued or effective during the fiscal year had, or is expected to have, a material impact on our Condensed Consolidated Financial Statements. Recently Adopted Accounting Pronouncements In September 2022, the FASB issued Accounting Standards Update 2022-04, " Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations " which requires that a buyer in a supplier finance program disclose additional information about the program for financial statement users including a rollforward of those obligations. The Company adopted the standard as of October 1, 2023, except for amendments relating to the rollforward requirement, which is effective for fiscal years beginning after December 15, 2023.

Restructuring Charges (Tables)

Restructuring Charges (Tables)	3 Months Ended
	Dec. 31, 2024
Restructuring Charges [Abstract]
Schedule of Charges Related to Restructuring Activities	Three Months Ended December 31, 2024 2023 Severance and related costs $ 0.5 $ 3.9 Asset write-off and accelerated depreciation 1.0 0.1 Consulting, project implementation and management, and other exit costs 0.9 2.8 Total restructuring and repositioning charges $ 2.4 $ 6.8 Consolidation of Mexico Facilities In fiscal 2024, the Company announced certain operational and organizational steps designed to streamline the Company’s operations and supply chain by consolidating its current Mexico operations in Obregon and Mexico City into a single facility in Aguascalientes, Mexico. As a result of these actions, the Company is anticipating incurring restructuring and repositioning charges of $18 in fiscal 2025 and is expected to be completed by the second quarter of fiscal 2026. Three Months Ended December 31, 2024 2023 Severance and related benefit costs (1) $ (0.3) $ — Consulting, project implementation and management, and other exit costs 2.1 — Total restructuring and repositioning charges (2) $ 1.8 $ — (1) Due to natural workforce attrition, the Company has recorded an adjustment to the severance accrual that was recorded as of September 30, 2024. (2) The Company does not include restructuring costs in the results of its reportable segments; however, these charges are related to the Wet Shave segment.

Earnings per Share (Tables)

Earnings per Share (Tables)	3 Months Ended
	Dec. 31, 2024
Earnings Per Share [Abstract]
Schedule of Weighted-Average Shares Outstanding	The following is the reconciliation between the number of weighted-average shares used in the basic and diluted net (loss) earnings per share calculation: Three Months Ended 2024 2023 Basic weighted-average shares outstanding 48.7 50.1 Effect of dilutive securities: Options, RSE and PRSE awards — 0.4 Total dilutive securities — 0.4 Diluted weighted-average shares outstanding 48.7 50.5 For the three months ended December 31, 2024, the calculation of diluted weighted-average shares outstanding excludes 0.5 of options, RSE and PRSE awards that would have otherwise been dilutive, because the Company reported a net loss.
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following weighted-average common shares were excluded from the calculation of diluted net (loss) earnings per share because the effect of including these awards was antidilutive. Three Months Ended 2024 2023 Options, RSE and PRSE awards 1.4 1.9

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	3 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The following table sets forth intangible assets by class: December 31, 2024 September 30, 2024 Carrying Accumulated Net Carrying Accumulated Net Indefinite lived Trade names and brands $ 592.2 $ — $ 592.2 $ 597.7 $ — $ 597.7 Amortizable Trade names and brands $ 339.6 $ 107.7 $ 231.9 $ 339.8 $ 104.0 $ 235.8 Technology and patents 79.2 76.9 2.3 79.7 77.3 2.4 Customer related and other 269.7 161.8 107.9 272.5 159.9 112.6 Amortizable intangible assets 688.5 346.4 342.1 692.0 341.2 350.8 Total intangible assets $ 1,280.7 $ 346.4 $ 934.3 $ 1,289.7 $ 341.2 $ 948.5
Schedule of Amortizable Intangible Assets	The following table sets forth intangible assets by class: December 31, 2024 September 30, 2024 Carrying Accumulated Net Carrying Accumulated Net Indefinite lived Trade names and brands $ 592.2 $ — $ 592.2 $ 597.7 $ — $ 597.7 Amortizable Trade names and brands $ 339.6 $ 107.7 $ 231.9 $ 339.8 $ 104.0 $ 235.8 Technology and patents 79.2 76.9 2.3 79.7 77.3 2.4 Customer related and other 269.7 161.8 107.9 272.5 159.9 112.6 Amortizable intangible assets 688.5 346.4 342.1 692.0 341.2 350.8 Total intangible assets $ 1,280.7 $ 346.4 $ 934.3 $ 1,289.7 $ 341.2 $ 948.5 Amortization expenses were $7.8 and $7.8 for the three months ended December 31, 2024 and 2023, respectively. Estimated amortization expense for amortizable intangible assets is as follows: Estimated amortization expense Remainder of fiscal year 2025 $ 23.2 2026 30.6 2027 30.4 2028 30.4 2029 30.3 2030 30.3 Thereafter 166.9

Supplemental Balance Sheet In_2

Supplemental Balance Sheet Information (Tables)	3 Months Ended
	Dec. 31, 2024
Supplemental Balance Sheet Information [Abstract]
Supplement Balance Sheet Information	December 31, September 30, Other Current Assets Prepaid expenses $ 79.8 $ 76.4 Value added tax receivables 34.1 40.0 Income taxes receivable 18.5 14.7 Other 15.2 9.1 Total other current assets $ 147.6 $ 140.2 Other Current Liabilities Accrued advertising and sales promotion $ 23.3 $ 26.3 Accrued trade allowances 23.8 28.7 Accrued salaries, vacations and incentive compensation 32.1 78.6 Income taxes payable 9.2 13.6 Returns reserve 24.7 50.3 Accrued interest 9.5 24.7 Other 105.4 97.6 Total other current liabilities $ 228.0 $ 319.8 Other Liabilities Pensions and other retirement benefits $ 43.6 $ 45.6 Other 125.6 129.4 Total other liabilities $ 169.2 $ 175.0

Debt (Tables)

Debt (Tables)	3 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
Schedule of Long-term Debt	The detail of long-term debt was as follows: December 31, September 30, Senior notes, fixed interest rate of 5.5%, due 2028 $ 750.0 $ 750.0 Senior notes, fixed interest rate of 4.1%, due 2029 500.0 500.0 U.S. Revolving Credit Facility 199.0 34.0 Total 1,449.0 1,284.0 Less unamortized debt issuance costs and discount (1) 8.4 9.0 Total long-term debt $ 1,440.6 $ 1,275.0 (1) As of December 31, 2024, debt issuance costs were $5.0 and $3.4 related to the Senior Notes due 2028 and the Senior Notes due 2029, respectively. As of September 30, 2024, debt issuance costs were $5.4 and $3.6 related to the Senior Notes due 2028 and the Senior Notes due 2029, respectively.

Retirement Plans (Tables)

Retirement Plans (Tables)	3 Months Ended
	Dec. 31, 2024
Retirement Benefits [Abstract]
Schedule of Net Periodic Pension and Postretirement Cost (Benefit)	The Company’s net periodic pension and postretirement costs for its material plans were as follows: Three Months Ended 2024 2023 Service cost $ 0.6 $ 0.5 Interest cost 4.5 5.3 Expected return on plan assets (5.4) (4.9) Recognized net actuarial loss 0.6 0.4 Net periodic cost $ 0.3 $ 1.3

Equity (Tables)

Equity (Tables)	3 Months Ended
	Dec. 31, 2024
Equity [Abstract]
Dividends Declared	Dividends Dividend activity in the three months ended December 31, 2024 are as follows: Date Declared Record Date Payable Date Amount Per Share August 6, 2024 September 4, 2024 October 3, 2024 $ 0.15 October 31, 2024 December 3, 2024 January 8, 2025 $ 0.15

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss (Tables)	3 Months Ended
	Dec. 31, 2024
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of Changes in Accumulated Other Comprehensive Loss	The following table presents the changes in Accumulated Other Comprehensive (Loss) Income (“AOCI”), net of tax, by component: Foreign Pension and Hedging Total Balance as of October 1, 2024 $ (68.3) $ (84.8) $ (1.7) $ (154.8) Other comprehensive income (loss), net of tax (48.3) (0.1) 5.4 (43.0) Reclassifications to earnings — 0.5 (0.4) 0.1 Balance as of December 31, 2024 $ (116.6) $ (84.4) $ 3.3 $ (197.7) Foreign Pension and Hedging Total Balance as of October 1, 2023 $ (86.9) $ (86.0) $ 2.9 $ (170.0) Other comprehensive income (loss), net of tax 27.0 (0.4) (2.3) 24.3 Reclassifications to earnings — 0.3 (1.1) (0.8) Balance as of December 31, 2023 $ (59.9) $ (86.1) $ (0.5) $ (146.5)

Financial Instruments and Ris_2

Financial Instruments and Risk Management (Tables)	3 Months Ended
	Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Fair Values of Derivative Instruments	The following table provides estimated fair values of derivative instruments: Fair Value of Assets (Liabilities) as of (1) December 31, September 30, Derivatives designated as cash flow hedging relationships: Foreign currency contracts $ 4.8 $ (2.4) Derivatives not designated as cash flow hedging relationships: Foreign currency contracts $ — $ 0.1 (1) Derivative assets are presented in Other current assets or Other assets. Derivative liabilities are presented in Other current liabilities or Other liabilities.
Schedule of Gains and Losses on Derivative Instruments	The following table provides the pre-tax amounts of gains and losses on derivative instruments: Three Months Ended 2024 2023 Derivatives designated as cash flow hedging relationships: Foreign currency contracts Gain recognized in OCI (1) $ 7.7 $ 1.1 Gain reclassified from AOCI into income (1) (2) 0.5 1.6 Derivatives not designated as cash flow hedging relationships: Foreign currency contracts Gain recognized in income (2) $ 0.9 $ 1.1 (1) Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and have been deemed highly effective by the Company in offsetting associated risk. (2)
Schedule of Offsetting Assets and Liabilities	The following table provides financial assets and liabilities for balance sheet offsetting: As of December 31, 2024 As of September 30, 2024 Assets (1) Liabilities (2) Assets (1) Liabilities (2) Foreign currency contracts Gross amounts of recognized assets (liabilities) $ 4.8 $ — $ 0.1 $ (2.7) Gross amounts offset in the balance sheet — — — 0.3 Net amounts of assets (liabilities) presented in the balance sheet $ 4.8 $ — $ 0.1 $ (2.4) (1) All derivative assets are presented in Other current assets or Other assets on the Condensed Consolidated Balance Sheets. (2) All derivative liabilities are presented in Other current liabilities or Other liabilities on the Condensed Consolidated Balance Sheets.
Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis	The following table sets forth the Company’s financial assets and liabilities, which are carried at fair value and measured on a recurring basis during the period, all of which are classified as Level 2 within the fair value hierarchy: December 31, September 30, Assets (Liabilities) at estimated fair value: Deferred compensation liability $ (21.5) $ (21.1) Derivatives - foreign currency contracts asset 4.8 (2.3) Net assets (liabilities) at estimated fair value $ (16.7) $ (23.4)

Segment Data (Tables)

Segment Data (Tables)	3 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
Schedule of Segment Sales and Profitability	Segment net sales and profitability are presented below: Three Months Ended 2024 2023 Net Sales Wet Shave $ 294.5 $ 301.7 Sun and Skin Care 120.6 115.4 Feminine Care 63.3 71.8 Total net sales $ 478.4 $ 488.9 Segment Profit Wet Shave $ 46.6 $ 53.7 Sun and Skin Care (3.4) (1.3) Feminine Care 3.2 7.3 Total segment profit 46.4 59.7 General corporate and other expenses (11.6) (16.2) Amortization of intangibles (7.8) (7.8) Interest and other expense, net (21.1) (20.1) Restructuring and repositioning expenses (1) (4.2) (6.8) Acquisition and integration costs (2) (0.5) (0.7) Sun Care reformulation costs (3) (1.0) (0.5) Wet Ones manufacturing plant fire (4) — (1.5) Gain on investment (5) 0.9 — Other project and related costs (6) (2.8) (0.1) Total (loss) earnings before income taxes $ (1.7) $ 6.0 (1) The Company recorded $4.2 and $6.8 for the three months ended December 31, 2024 and 2023, respectively, related to actions to strengthen its operating model and improve manufacturing and supply chain efficiency and productivity. There were no amounts included in pre-tax SG&A or pre-tax Cost of products sold for both the three months ended December 31, 2024 and 2023. See Note 2 of the Notes to Condensed Consolidated Financial Statements. (2) Includes pre-tax SG&A of $0.5 and $0.7 for the three months ended December 31, 2024 and 2023, respectively, for the acquisition of Billie, Inc. on November 29, 2021. (3) Includes pre-tax research and development costs of $1.0 and $0.5 for the ended December 31, 2024 and 2023, respectively, related to the reformulation, recall and destruction of certain Sun Care products. (4) On December 1, 2023, a fire occurred at our Wet Ones manufacturing plant in Sidney, Ohio. There were no injuries reported and damage was limited to a single manufacturing process. As a consequence of the fire damage, there was a partial shutdown of the operations that manufacture Wet Ones raw materials. During the three months ended December 31, 2023, the Company incurred $1.5 in costs related to incremental material charges, labor and absorption as a result of the fire. (5) Includes pre-tax gain of $0.9 for the three months ended December 31, 2024 on the fair value measurement of an equity method investment. (6) Includes pre-tax SG&A of $2.8 and $0.1 for the three months ended December 31, 2024 and 2023, respectively, related to certain corporate project and other related costs.
Schedule of Sales by Geographic Area	The following table presents the Company’s net sales by geographic area: Three Months Ended 2024 2023 Net Sales to Customers United States $ 244.6 $ 254.2 International 233.8 234.7 Total net sales $ 478.4 $ 488.9
Schedule of Supplemental Product Information	Supplemental product information is presented below for net sales: Three Months Ended 2024 2023 Razors and blades $ 267.4 $ 270.5 Tampons, pads, and liners 63.3 71.8 Sun care products 47.4 51.0 Grooming products 53.0 46.8 Wipes and other skin care 20.2 17.6 Shaving gels and creams 27.1 31.2 Total net sales $ 478.4 $ 488.9

Background and Basis of Prese_2

Background and Basis of Presentation (Details)	3 Months Ended
	Dec. 31, 2024 USD ($) country	Sep. 30, 2024 USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of countries in which Edgewell operates	20
Number of countries with retail operations	50
Number of Reportable Segments	3
Supplier Finance Program, Obligation | $	$ 17.3	$ 16.9

Restructuring Charges (Schedule

Restructuring Charges (Schedule of Charges Related to Restructuring Activities) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Sep. 30, 2024
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 4.2	$ 6.8
Restructuring and related costs	4.2	6.8
Restructuring Reserve	17.6
Employee Severance [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	17.6		$ 20.7
Restructuring charges, charge to income	0.2
Utilized - Cash Payments	(1.4)
Utilized - Non-Cash	(1.9)
Asset Impairment and Accelerated Depreciation [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	0
Restructuring charges, charge to income	1
Utilized - Non-Cash	(1)
Other Restructuring [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	0		0.7
Restructuring charges, charge to income	3
Utilized - Cash Payments	(2.3)
Utilized - Non-Cash	(1.4)
Operating Model Redesign
Restructuring Cost and Reserve [Line Items]
Severance Costs	0.5	3.9
Other Restructuring Costs	0.9	2.8
Restructuring charges	2.4	6.8
Restructuring Reserve	2.9
Asset Impairment and Accelerated Depreciation	1	$ 0.1
Operating Model Redesign | Employee Severance [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	2.9		5.1
Restructuring charges, charge to income	0.5
Utilized - Cash Payments	(1.4)
Utilized - Non-Cash	(1.3)
Operating Model Redesign | Asset Impairment and Accelerated Depreciation [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges, charge to income	1
Utilized - Non-Cash	(1)
Operating Model Redesign | Other Restructuring [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	0		0.7
Restructuring charges, charge to income	0.9
Utilized - Cash Payments	(0.9)
Utilized - Non-Cash	(0.7)
Consolidation of Mexico Facilities
Restructuring Cost and Reserve [Line Items]
Severance Costs	(0.3)
Other Restructuring Costs	2.1
Restructuring charges	1.8
Restructuring Reserve	14.7
Consolidation of Mexico Facilities | Employee Severance [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	14.7		15.6
Restructuring charges, charge to income	(0.3)
Utilized - Cash Payments	0
Utilized - Non-Cash	(0.6)
Consolidation of Mexico Facilities | Other Restructuring [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	0		$ 0
Restructuring charges, charge to income	2.1
Utilized - Cash Payments	(1.4)
Utilized - Non-Cash	$ (0.7)

Restructuring Charges (Schedu_2

Restructuring Charges (Schedule of Restructuring Activities and Related Accruals) (Details) - USD ($)	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Restructuring Reserve [Roll Forward]
Restructuring and related costs	$ 4,200,000	$ 6,800,000
Ending Balance	17,600,000
Restructuring and Related Cost, Expected Cost	11
Employee Severance [Member]
Restructuring Reserve [Roll Forward]
Beginning Balance	20,700,000
Utilized - Cash Payments	(1,400,000)
Utilized - Non-Cash	(1,900,000)
Ending Balance	17,600,000
Other Restructuring [Member]
Restructuring Reserve [Roll Forward]
Beginning Balance	700,000
Utilized - Cash Payments	(2,300,000)
Utilized - Non-Cash	(1,400,000)
Ending Balance	0
Asset Impairment and Accelerated Depreciation [Member]
Restructuring Reserve [Roll Forward]
Utilized - Non-Cash	(1,000,000)
Ending Balance	$ 0

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Income tax provision	$ 0.4	$ 1.2
(Loss) earnings before income taxes	$ (1.7)	$ 6
Effective tax rate	(21.70%)	20.10%

Earnings per Share (Schedule of

Earnings per Share (Schedule of Weighted-Average Shares Outstanding) (Details) - shares shares in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Schedule Of Weighted Average Number Of Shares [Line Items]
Basic weighted-average shares outstanding (in shares)	48.7	50.1
Effect of dilutive securities (in shares)	0	0.4
Diluted weighted-average shares outstanding (in shares)	48.7	50.5
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Earnings Per Share, Potentially Dilutive Securities	0.5
RSE and PRSE awards
Schedule Of Weighted Average Number Of Shares [Line Items]
Effect of dilutive securities (in shares)	0	0.4
Share options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive awards excluded from the calculation of diluted weighted-average shares outstanding (in shares)	1.4	1.9

Property, Plant, and Equipment

Property, Plant, and Equipment (Details) - USD ($)	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Sep. 30, 2024
Property, Plant and Equipment [Line Items]
Land	$ 18,300,000		$ 18,900,000
Buildings and Improvements, Gross	145,900,000		147,900,000
Machinery and Equipment, Gross	1,112,000,000		1,132,700,000
Capitalized Computer Software, Gross	64,700,000		62,500,000
Construction in Progress, Gross	60,900,000		62,000,000
Property, Plant and Equipment, Gross	1,401,800,000		1,424,000,000
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	(1,059,100,000)		(1,074,900,000)
Property, plant and equipment, net	342,700,000		$ 349,100,000
Depreciation	12,900,000	$ 13,600,000
Capitalized Computer Software, Amortization	1,100,000	$ 1,100,000
Non-Cash Investing Activity - Acqusition of PP&E	$ 5,400,000

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets (Schedule of Goodwill) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2024	Sep. 30, 2024
Goodwill [Line Items]
Goodwill, Gross	$ 1,699.7	$ 1,709.6
Accumulated goodwill impairment loss	371	371
Goodwill [Roll Forward]
Beginning balance	1,338.6
Cumulative translation adjustment	9.9
Ending balance	1,328.7
Wet Shave
Goodwill [Line Items]
Goodwill, Gross	1,139.7	1,146
Accumulated goodwill impairment loss	369	369
Goodwill [Roll Forward]
Beginning balance	777
Cumulative translation adjustment	6.3
Ending balance	770.7
Sun and Skin Care
Goodwill [Line Items]
Goodwill, Gross	356.3	357.4
Accumulated goodwill impairment loss	2	2
Goodwill [Roll Forward]
Beginning balance	355.4
Cumulative translation adjustment	1.1
Ending balance	354.3
Feminine Care
Goodwill [Line Items]
Goodwill, Gross	203.7	206.2
Accumulated goodwill impairment loss	0	$ 0
Goodwill [Roll Forward]
Beginning balance	206.2
Cumulative translation adjustment	2.5
Ending balance	$ 203.7

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets (Schedule of Amortizable Intangible Assets) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Sep. 30, 2024
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	$ 688.5		$ 692
Amortizable intangible assets, accumulated amortization	346.4		341.2
Amortizable intangible assets, net	342.1		350.8
Other intangible assets, net	934.3		948.5
Intangible Assets, Gross (Excluding Goodwill)	1,280.7		1,289.7
Amortization of intangibles	7.8	$ 7.8
Amortizable intangible assets, amortization expense, remainder of 2023	23.2
Amortizable intangible assets, amortization expense, fiscal 2024	30.6
Amortizable intangible assets, amortization expense, fiscal 2025	30.4
Amortizable intangible assets, amortization expense, fiscal 2026	30.4
Amortizable intangible assets, amortization expense, fiscal 2027	30.3
Amortizable intangible assets, amortization expense, fiscal 2028	30.3
Amortizable intangible assets, amortization expense, after fiscal 2028	166.9
Indefinite-lived intangible assets	592.2		597.7
Trade names and brands
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	339.6		339.8
Amortizable intangible assets, accumulated amortization	107.7		104
Amortizable intangible assets, net	231.9		235.8
Technology and patents
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	79.2		79.7
Amortizable intangible assets, accumulated amortization	76.9		77.3
Amortizable intangible assets, net	2.3		2.4
Customer related and other
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	269.7		272.5
Amortizable intangible assets, accumulated amortization	161.8		159.9
Amortizable intangible assets, net	$ 107.9		$ 112.6

Supplemental Balance Sheet In_3

Supplemental Balance Sheet Information (Details) - USD ($) $ in Millions	Dec. 31, 2024	Sep. 30, 2024
Other Current Assets
Prepaid expenses	$ 79.8	$ 76.4
Value added tax receivables	34.1	40
Income taxes receivable	18.5	14.7
Other	15.2	9.1
Total other current assets	147.6	140.2
Other Current Liabilities
Accrued advertising and sales promotion	23.3	26.3
Accrued trade allowances	23.8	28.7
Accrued salaries, vacations and incentive compensation	32.1	78.6
Income taxes payable	9.2	13.6
Returns reserve	24.7	50.3
Accrued interest	9.5	24.7
Other	105.4	97.6
Total other current liabilities	228	319.8
Other Liabilities
Pensions and other retirement benefits	43.6	45.6
Other	125.6	129.4
Total other liabilities	$ 169.2	$ 175

Accounts Receivable Facility (N

Accounts Receivable Facility (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Sep. 30, 2024
Accounts receivable sales agreement
Transfer of Financial Assets Accounted for as Sales [Line Items]
Loss on sale of accounts receivable	$ 1.1	$ 1.2
Transfer of Financial Assets Accounted for as Sales, Cash Proceeds Received for Assets Derecognized, Amount	223.9	$ 216.1
Accounts receivable sales agreement
Transfer of Financial Assets Accounted for as Sales [Line Items]
Transfer of accounts receivable, sales amount derecognized	$ 81.5		$ 88.6

Debt (Details)

Debt (Details) - USD ($) $ in Millions	Dec. 31, 2024	Sep. 30, 2024
Debt Instrument [Line Items]
Total	$ 1,449	$ 1,284
Long-term debt	1,440.6	1,275
Notes payable	27.2	24.5
Unamortized debt issuance costs	$ 8.4	9
Short-Term Debt, Weighted Average Interest Rate, at Point in Time	3.80%
Senior notes | Senior Notes, Due 2028
Debt Instrument [Line Items]
Total	$ 750	750
Unamortized debt issuance costs	5	5.4
Senior notes | Senior Notes, Due 2029
Debt Instrument [Line Items]
Total	500	500
Unamortized debt issuance costs	3.4	3.6
Revolving credit facility
Debt Instrument [Line Items]
Total	$ 199	$ 34

Retirement Plans (Details)

Retirement Plans (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Retirement Benefits [Abstract]
Service cost	$ 0.6	$ 0.5
Interest cost	4.5	5.3
Expected return on plan assets	(5.4)	(4.9)
Recognized net actuarial loss	0.6	0.4
Net periodic cost	0.3	1.3
Defined Benefit Plan Disclosure [Line Items]
Service cost	0.6	0.5
Interest cost	4.5	5.3
Defined Benefit Plan, Expected Return (Loss) on Plan Assets	5.4	4.9
Defined Benefit Plan, Amortization of Gain (Loss)	(0.6)	(0.4)
Defined Benefit Plan, Net Periodic Benefit Cost (Credit)	$ 0.3	$ 1.3

Equity (Details)

Equity (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended
	Dec. 31, 2024	Sep. 30, 2024	Dec. 31, 2023	Jan. 26, 2018
Equity [Abstract]
Share repurchase authorization				10
Treasury shares repurchased (in shares)	0.8
Treasury shares repurchased (in usd)	$ 30.1		$ 15.5
Share repurchase authorization, remaining	2.2
Dividends declared	$ 7.1
Dividends to common shareholders	$ 7.9		$ 7.6
Dividends declared (per share)	$ 0.15	$ 0.15
Dividends declared (per share)	$ 0.15	$ 0.15
us-gaap_TreasuryStockValueAcquiredCostMethodlessexcisetax	$ 30.3

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Schedule of Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ (154.8)	$ (170)
OCI before reclassifications	(43)	24.3
Reclassifications to earnings	0.1	(0.8)
Ending balance	(197.7)	(146.5)
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(68.3)	(86.9)
OCI before reclassifications	(48.3)	27
Reclassifications to earnings	0	0
Ending balance	(116.6)	(59.9)
Pension and Post-retirement Activity
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(84.8)	(86)
OCI before reclassifications	(0.1)	(0.4)
Reclassifications to earnings	0.5	0.3
Ending balance	(84.4)	(86.1)
Hedging Activity
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(1.7)	2.9
OCI before reclassifications	5.4	(2.3)
Reclassifications to earnings	(0.4)	(1.1)
Ending balance	$ 3.3	$ (0.5)

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss (Schedule of Reclassifications out of Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassifications to earnings	$ (0.1)	$ 0.8
Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
OCI Cash flow hedge, reclassification to earnings, tax	0.1	0.5
Other comprehensive income, reclassification to earnings, cash flow hedges, after tax	0.4	1.1
Amortization of defined benefit pension and postretirement items, actuarial losses, before tax	(0.6)	(0.4)
Amortization of defined benefit pension and postretirement items, tax	(0.1)	(0.1)
Amortization of defined benefit pension and postretirement items, after tax	(0.5)	(0.3)
Reclassifications to earnings	$ (0.1)	$ 0.8

Financial Instruments and Ris_3

Financial Instruments and Risk Management (Narrative) (Details) $ in Millions	3 Months Ended		12 Months Ended
	Dec. 31, 2024 USD ($) contracts	Dec. 31, 2023 USD ($)	Sep. 30, 2024 USD ($)
Derivative [Line Items]
Long-term debt	$ 1,449		$ 1,284
Fixed rate
Derivative [Line Items]
Long-term debt	1,250		1,250
Fair value of long-term debt	$ 1,162.4		1,180
Not designated as hedge | FX contract
Derivative [Line Items]
Open foreign currency contracts | contracts	1
Derivative, notional amount	$ 9
Gain (loss) recognized in income	$ 0.9	$ 1.1
Cash flow hedge | Designated as hedge | FX contract
Derivative [Line Items]
Open foreign currency contracts | contracts	64
Derivative, notional amount	$ 99.7
Gain (loss) recognized in OCI	$ 4.8		$ (2.4)

Financial Instruments and Ris_4

Financial Instruments and Risk Management (Schedule of Fair Values of Derivative Instruments) (Details) - FX contract - USD ($) $ in Millions	Dec. 31, 2024	Sep. 30, 2024
Not designated as hedge
Derivatives, Fair Value [Line Items]
Estimated fair value of derivatives	$ 0	$ 0.1
Cash flow hedge | Designated as hedge
Derivatives, Fair Value [Line Items]
Estimated fair value of derivatives	$ 4.8	$ (2.4)

Financial Instruments and Ris_5

Financial Instruments and Risk Management (Schedule of Gains and Losses on Derivative Instruments) (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Sep. 30, 2024
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]	Nonoperating Income (Expense)	Nonoperating Income (Expense)
FX contract | Designated as hedge | Cash flow hedge
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in OCI	$ 4.8		$ (2.4)
Unrealized Gain (Loss) on Interest Rate Cash Flow Hedges, Pretax, Accumulated Other Comprehensive Income (Loss)	7.7	$ 1.1
FX contract | Not designated as hedge
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in income	$ 0.9	$ 1.1

Financial Instruments and Ris_6

Financial Instruments and Risk Management (Schedule of Offsetting Assets and Liabilities) (Details) - FX contract - USD ($) $ in Millions	Dec. 31, 2024	Sep. 30, 2024
Derivative [Line Items]
Gross amounts of recognized assets	$ 4.8	$ 0.1
Gross amounts of recognized liabilities	0	(2.7)
Gross amounts offset in the balance sheet	0	0
Gross amounts offset in the balance sheet	0	0.3
Net amounts of assets presented in the balance sheet	4.8	0.1
Net amounts of liabilities presented in the balance sheet	$ 0	$ (2.4)

Financial Instruments and Ris_7

Financial Instruments and Risk Management (Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis) (Details) - Recurring fair value measurement - Level 2 - USD ($) $ in Millions	Dec. 31, 2024	Sep. 30, 2024
Derivative [Line Items]
Deferred compensation liability	$ (21.5)	$ (21.1)
Derivatives - foreign currency contracts asset	4.8	(2.3)
Net assets (liabilities) at estimated fair value	$ (16.7)	$ (23.4)

Segment Data (Schedule of Segme

Segment Data (Schedule of Segment Sales and Profitability) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Segment Reporting Information [Line Items]
Net sales	$ 478.4	$ 488.9
Segment profit	20.3	26.1
Acquisition and integration costs	(0.5)	(0.7)
Sun Care reformulation costs	(1)	(0.5)
Wet Ones manufacturing plant fire	0	1.5
Gain (Loss) on Investments	0.9
Other project costs	2.8	0.1
Amortization of Intangible Assets	(7.8)	(7.8)
Interest Expense and Other Nonoperating (Income) Expense, Net	(21.1)	(20.1)
(Loss) earnings before income taxes	(1.7)	6
Restructuring Charges	(4.2)	(6.8)
Wet Shave
Segment Reporting Information [Line Items]
Net sales	294.5	301.7
Segment profit	46.6	53.7
Sun and Skin Care
Segment Reporting Information [Line Items]
Net sales	120.6	115.4
Segment profit	(3.4)	(1.3)
Feminine Care
Segment Reporting Information [Line Items]
Net sales	63.3	71.8
Segment profit	3.2	7.3
Corporate
Segment Reporting Information [Line Items]
General Corporate and Other Expenses	(11.6)	(16.2)
segment profit
Segment Reporting Information [Line Items]
Segment profit	46.4	59.7
Selling, general and administrative expenses
Segment Reporting Information [Line Items]
Acquisition and integration costs	$ (0.5)	$ (0.7)

Segment Data Segment Data (Sche

Segment Data Segment Data (Schedule of Sales by Geographical Area) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Revenue from External Customer [Line Items]
Net sales	$ 478.4	$ 488.9
United States
Revenue from External Customer [Line Items]
Net sales	244.6	254.2
International
Revenue from External Customer [Line Items]
Net sales	$ 233.8	$ 234.7

Segment Data (Schedule of Suppl

Segment Data (Schedule of Supplemental Product Information) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Revenue from External Customer [Line Items]
Net sales	$ 478.4	$ 488.9
Razors and blades
Revenue from External Customer [Line Items]
Net sales	267.4	270.5
Tampons, pads and liners
Revenue from External Customer [Line Items]
Net sales	63.3	71.8
Sun care products
Revenue from External Customer [Line Items]
Net sales	47.4	51
Grooming products
Revenue from External Customer [Line Items]
Net sales	53	46.8
Wipes and other skin care products
Revenue from External Customer [Line Items]
Net sales	20.2	17.6
Shaving gels and creams
Revenue from External Customer [Line Items]
Net sales	$ 27.1	$ 31.2

Commitment and Contingencies (D

Commitment and Contingencies (Details)	3 Months Ended
	Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure	Commitments and Contingencies Legal Proceedings The Company and its subsidiaries are subject to a number of legal proceedings in various jurisdictions arising out of its operations during the ordinary course of business. Many of these legal matters are in preliminary stages and involve complex issues of law and fact and may proceed for protracted periods of time. The amount of liability, if any, from these proceedings cannot be determined with certainty. The Company reviews its legal proceedings and claims, regulatory reviews and inspections and other legal proceedings on an ongoing basis and follows appropriate accounting guidance when making accrual and disclosure decisions. The Company establishes accruals for those contingencies when the incurrence of a loss is probable and can be reasonably estimated and discloses the amount accrued and the amount of a reasonably possible loss in excess of the amount accrued if such disclosure is necessary for its financial statements to not be misleading. The Company does not record liabilities when the likelihood that the liability has been incurred is probable, but the amount cannot be reasonably estimated. Based upon present information, the Company believes that its liability, if any, arising from such pending legal proceedings, asserted legal claims, and known potential legal claims which are likely to be asserted, is not reasonably likely to be material to its financial position, results of operations or cash flows, when taking into account established accruals for estimated liabilities.

Inventory (Details)

Inventory (Details) - USD ($) $ in Millions	Dec. 31, 2024	Sep. 30, 2024
Inventory [Line Items]
Inventory, Raw Materials, Net of Reserves	$ 83.3	$ 82.6
Inventory, Work in Process, Net of Reserves	93.4	91.8
Inventory, Finished Goods, Net of Reserves	324.9	302.9
Inventories	$ 501.6	$ 477.3